Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding

Nature Medicine

Volumn 21, Issue 3, 2015, Pages 217-219

  Blennow, Kaj ^a   Zetterberg, Henrik ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; NEUROGRANIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT; TAU PROTEIN;

ANTIGEN BINDING; CEREBROSPINAL FLUID; DENDRITIC SPINE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; HUMAN; LIMIT OF QUANTITATION; LONG TERM POTENTIATION; NERVE CELL; NERVE DEGENERATION; NEUROIMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY; ALZHEIMER DISEASE; IMMUNOASSAY; METABOLISM; PHOSPHORYLATION; PROCEDURES;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; HUMANS; IMMUNOASSAY; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TAU PROTEINS;

EID: 84924421182     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3810     Document Type: Short Survey

References (9)

1. Blennow, K., Hampel, H., Weiner, M. & Zetterberg, H. Nat. Rev. Neurol. 6, 131-144 (2010).
2. Savage, M.J. et al. J. Neurosci. 34, 2884-2897 (2014).
3. Hölttä, M. et al. PLoS ONE 8, e66381 (2013).
4. Yang, T. et al. Alzheimers Dement. 9, 99-112 (2013).
5. Rissin, D.M. et al. Nat. Biotechnol. 28, 595-599 (2010).
6. Randall, J. et al. Resuscitation 84, 351-356 (2013).
7. Zetterberg, H. et al. Alzheimers Res. Ther. 5, 9 (2013).
8. Meredith, J.E. Jr. et al. PLoS ONE 8, e76523 (2013).
9. Kvartsberg, H. et al. Alzheimers Dement. doi:10.1016/ j.jalz.2014.10.009 (19 December 2014).